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Abstract
Background: Yersinia pestis is a gram-negative bacterium that causes plague, a disease linked historically to the
Black Death in Europe during the Middle Ages and to several outbreaks during the modern era. Metabolism in Y.
pestis displays remarkable flexibility and robustness, allowing the bacterium to proliferate in both warm-blooded
mammalian hosts and cold-blooded insect vectors such as fleas.
Results: Here we report a genome-scale reconstruction and mathematical model of metabolism for Y. pestis CO92
and supporting experimental growth and metabolite measurements. The model contains 815 genes, 678 proteins,
963 unique metabolites and 1678 reactions, accurately simulates growth on a range of carbon sources both
qualitatively and quantitatively, and identifies gaps in several key biosynthetic pathways and suggests how those
gaps might be filled. Furthermore, our model presents hypotheses to explain certain known nutritional
requirements characteristic of this strain.
Conclusions: Y. pestis continues to be a dangerous threat to human health during modern times. The Y. pestis
genome-scale metabolic reconstruction presented here, which has been benchmarked against experimental data
and correctly reproduces known phenotypes, provides an in silico platform with which to investigate the
metabolism of this important human pathogen.
Background
Yersinia pestis is a gram-negative bacterium within the
family Enterobacteriaceae that, along with Yersinia pseu-
dotuberculosis and Yersinia enterocolitica,i so n eo f
three members of its genus that can cause disease in
humans. Y. pestis diverged from Y. pseudotuberculosis
only 1,500 - 20,000 years ago, but Y. pestis and Y. pseu-
dotuberculosis diverged from Y. enterocolitica in the
more distant past [1]. Despite their close evolutionary
relationship, the diseases they cause differ markedly.
Whereas Y. pseudotuberculosis and Y. enterocolitica are
primarily gastrointestinal pathogens in humans, Y. pestis
infections lead to a systemic disease known as plague
that can become fatal rapidly. In the last 2000 years,
there have been three distinct outbreaks of plague that
have led to a large number of fatalities: the Justinian
plague between the 5
th and 7
th centuries, the Black
Death in Europe between the 13
th and 15
th centuries,
and the modern plague from the latter half of the 1800s
to the present. These outbreaks of fatal infections that
continue to occur [2,3], the recent isolation of a multi-
drug resistant strain [4], and the potential to develop
into a bioweapon all signify that Y. pestis remains a sig-
nificant threat to human health.
Most Y. pestis strains can be divided into three bio-
vars: Antigua, Mediavalis, and Orientalis, based on their
ability to ferment glycerol and reduce nitrate [5]. Biovar
Antigua strains can do both; biovar Mediavalis strains
can ferment glycerol but cannot reduce nitrate; and bio-
var Orientalis strains cannot ferment glycerol but can
reduce nitrate [5]. Moreover, each biovar has been
linked to one of the three pandemics. Biovar Antigua is
associated with the Justinian plague; biovar Mediavalis is
associated with the Black Death; and biovar Orientalis is
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these associations continues, however, as recent data
suggest that the Black Death might not have been
caused by strains belonging to Biovar Mediavalis but
rather by at least two strains that pre-date the emer-
gence of and are distinct from both biovar Mediavalis
and biovar Orientalis [6].
Here we present a metabolic network reconstruction
and corresponding mathematical model of metabolism
in Y. pestis CO92 (abbreviated YP CO92). This strain is
classified within Biovar Orientalis and is virulent to
humans, a feature which distinguishes the model pre-
sented here from one published previously for Y. pestis
91001 [7], which is avirulent to humans. We also pre-
sent a comprehensive analysis of pathways in the meta-
bolic network related to the biosynthesis and utilization
of key metabolites, acquire experimental data from
growth on several different carbon sources and compare
them to simulation results, and identify essential genes
that might constitute possible targets for antibiotic
development.
Results
Characteristics of the reconstruction
The Y. pestis CO92 metabolic reconstruction presented
here, iPC815, contains 815 genes, 678 proteins, 963
unique metabolites, and 1678 reactions. iPC815 was
assembled by comparison to existing E. coli [8], Salmo-
nella enterica serovar Typhimurium (hereafter referred
to as S. Typhimurium) [9], and Y. pestis strain 91001 [7]
metabolic reconstructions; genetic, protein, metabolite,
and biochemical data contained in databases such as
KEGG [10], BRENDA [11], MetaCyc [12], and PATRIC
[13]; and genus-, species-, and strain-specific informa-
tion gleaned from the literature. The model contains
distinct compartments for the cytoplasm and periplasm,
and inner and outer membrane transporters and their
associated transport reactions model the movement of
metabolites between the compartments. Of the 1678
reactions, 1539 (92%) are linked to their corresponding
genes and proteins through gene-protein-reaction asso-
ciations (GPRs); the majority of the 139 non-linked
reactions are transport reactions. Table 1 summarizes
the general features of iPC815, while Figure 1 depicts
the functional classification of the 815 genes according
to their COG function and presents a comparison to the
E. coli, S. Typhimurium LT2, and Y. pestis 91001 meta-
bolic reconstructions. The full list of all genes, metabo-
lites, reactions, and GPRs in iPC815 can be found in
Additional File 1.
The iPC815 model contains two biomass objective
f u n c t i o n s( B O F s )[ 1 4 ]t h a tw e r ed e r i v e df r o mt h et w o
BOFs developed for the existing Y. pestis 91001 recon-
struction [7] and modified as follows. First, iPC815
contains pathways for the biosynthesis of four Y. pestis
fatty acid acyl chains that are not explicitly modeled in
the Y. pestis 91001 reconstruction, specifically 14:0, 16:1,
16:0, and 18:1. These four comprise approximately 86%
of the total fatty acid composition in 29 Y. pestis isolates
during growth at 28°C [15]. Second, the lipopolysacchar-
ide (LPS) core oligosaccharide contains an uncommon
D-glycero-D-talo-oct-2-ulosonic acid (Ko) analog not
normally found in Gram-negative bacteria [16,17]. Both
of these features have been incorporated into the two
BOFs in iPC815.
Two BOFs are needed because the Y. pestis biomass
composition differs at 25-28°C versus 37°C. The signifi-
cance of these two temperatures stems from the two
types of hosts that Y. pestis infects in the natural envir-
onment: insect vectors at ambient temperature and
mammalian hosts with regulated body temperatures of
about 37°C. Accordingly, most laboratory studies of Y.
pestis are carried out at one or both of these tempera-
tures, and data from such studies have revealed two
principal differences in biomass composition at 25-28°C
versus 37°C. The first involves the lipopolysaccharide
(LPS) structure: at 37°C the LPS is composed of one
predominant core oligosaccharide and one predominant
lipid A isoform (tetraacyl 14:0), whereas at 25°C the LPS
is composed of multiple structures for both [17]. The
second involves the fatty acid composition. Lipid
Table 1 Overview of iPC815
Category Subsystem Number
Genes 815
Proteins 678
Metabolites
Cytoplasm 873
Periplasm 398
External 281
Unique 963
Total 1552
Metabolic Reactions
Cytoplasm 932
Periplasm 133
GPR-associated 1539
Non-GPR-associated 139
Unique 1678
Transport Reactions
Periplasm <=> External 281
Cytoplasm <=> Periplasm 332
Exchange Reactions 281
Biomass Objective Functions 2
Total Reactions 1961
To compile the number of unique metabolites, identical compounds
appearing in more than one compartment were only counted once. Unique
metabolic reactions encompass all reactions except exchange reactions and
biomass objective functions.
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Page 2 of 13Figure 1 A. Breakdown of the genes in iPC815 by COG classification. The COG classifications that make up the Miscellaneous category are:
K, L, Q, S, T, U, and V. B. Venn diagrams showing the overlap between iPC815 and published E. coli, S. Typhimurium, and Y. pestis 91001
reconstructions based on shared versus organism-specific reactions (E. coli and S. Typhimurium) and E.C. numbers (Y. pestis 91001). In the latter
case, an E.C. number associated with more than one reaction was only counted once. The low overlap between iPC815 and the Y. pestis 91001
reconstruction arises from the use of E.C. numbers to compare the two models rather than true biological differences between the two strains.
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Page 3 of 13measurements from Y. enterocolitica indicate that the
abundance of various fatty acids varies with growth tem-
perature [18], and we assume that this characteristic
holds for Y. pestis as well. The coefficients of the terms
representing the four fatty acids consequently differ
between the two BOFs. The 25-28°C BOF covers a tem-
perature range rather than a single value since the
experimental data on which this BOF was constructed
were taken over this range. Thus, the model also
assumes that the BOF composition does not change
appreciably between 25°C and 28°C.
Gap analysis of biosynthetic pathways
There were a number of gaps in iPC815 that initially
prevented the simulation of biomass formation. These
gaps consisted of reactions that were essential for simu-
lating growth but for which we could not identify
homologs in YP CO92 to the gene products in E. coli, S.
Typhimurium, or Y. pestis 91001 that catalyze the same
reactions. Each of these gaps constitutes testable experi-
mental hypotheses.
One gap occurs in the fatty acid biosynthesis pathway
(Figure 2A). The current annotation of the YP CO92
genome indicates that this strain contains the same full
suite of genes for fatty acid biosynthesis that E. coli and
S. Typhimurium have except one, the enoyl acyl-carrier
protein (ACP) reductase fabI. The enzyme encoded by
fabI catalyzes the reduction of the 2,3 double bond in
diverse acyl units during chain elongation [19], which is
an essential step in fatty acid biosynthesis. Consistent
with this data, the model cannot simulate growth with-
out this key enzyme. We have therefore included this
reaction in the model but it is not associated with a
gene or protein.
A similar gap appears in the lysine biosynthesis path-
way. Lysine is synthesized from aspartate in both E. coli
and S. Typhimurium through a series of nine enzyme-
catalyzed reactions [20], and YP CO92 has homologs to
each of the nine enzymes except one, ArgD (YPO0170)
(Figure 2B). In YP CO92, an IS element (IS100)i s
inserted directly into the ORF of YPO0170 [21], splitting
it into two and likely rendering it nonfunctional. Despite
this disruption, we experimentally tested and found no
evidence for lysine auxotrophy in YP CO92, a phenoty-
pic observation that suggests additional enzyme(s) can
catalyze the same reaction as YPO0170 during lysine
biosynthesis. We consequently searched for alternative
enzymes within the YP CO92 genome that can accept
both N-succinyl-L-2-amino-6-oxopimelate and any
molecule capable of donating an amino group as reac-
tants (Figure 2B), but found no support for such an
enzyme. Subsequently, we searched for paralogs within
t h eY PC O 9 2g e n o m et h a th a v eh o m o l o g yt ob o t h
YPO0170 fragments. The gene with the greatest
homology was YPO1962 with 59% nucleotide identity,
and we have assumed in the model that YPO1962 can
replace YPO0170 in the lysine biosynthetic pathway
(Figure 2B).
Phenotype simulations
Once all critical gaps necessary for in silico biomass for-
mation were filled, we deployed the model to compute
growth versus no-growth on different carbon, nitrogen,
phosphorus, and sulfur sources at both 25-28°C and 37°
C (Additional File 1). We focused particular attention
on rhamnose and melibiose since the ability or inability
to ferment these two sugars is one of several phenotypes
commonly used to classify different strains of Y. pestis.
For example, two of the best predictors for virulence in
h u m a n sa r et h ea b s e n c eo fr h a m n o s ef e r m e n t a t i o na n d
virulence in guinea pigs [22]. YP CO92 is known to be
lethal to humans, and consistent with this phenotype
there is no growth in silico if rhamnose is the sole car-
bon source. The model predicts that this outcome is
due to the overaccumulation of L-lactaldehyde. Specifi-
cally, the uptake pathway that connects periplasmic
rhamnose with central metabolism (Figure 3) leads to
the synthesis of a byproduct, L-lactaldehyde, that is not
removed through secretion, degradation, incorporation
into metabolism, or by any other means. Its production
via this pathway would therefore result in an infinite
accumulation of the compound, which is a thermodyna-
mically impossible outcome. On the other hand, the
melibiose utilization pathway appears to be intact and
thermodynamically consistent. We assume that a general
outer membrane porin allows passage of melibiose from
the extracellular space into the periplasm, after which
an inner membrane sodium:galactoside symporter
(YPO0995) appears capable of transporting melibiose
into the cytosol. Subsequently, the alpha-galactosidase
RafA (YPO1581) [23] connects imported melibiose with
central metabolism (Figure 3). This analysis implies that
regulation of these genes in the melibiose utilization
pathway, rather than the genes themselves, underlies the
inability of YP CO92 to utilize melibiose. We accounted
for this observation by retaining this set of reactions in
the model but deactivating the melibiose extracellular to
periplasm uptake reaction.
Using the individual components of the BCS chemical
medium to constrain the model [24], we next assessed
whether the model could recapitulate common amino
acid auxotrophies seen in epidemic strains of Y. pestis
such as CO92. These are methionine, phenylalanine,
and the combination of glycine and threonine [25,26].
Consistent with these data, the model exhibits auxotro-
phy for methionine and phenylalanine but growth still
occurs at a slow rate (~0.08 hr
-1) in silico in the absence
of both glycine and threonine as long as all other amino
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Page 4 of 13Figure 2 Essential gaps in key Y. pestis CO92 metabolic pathways. A. The last step during each fatty acid elongation cycle involves the
reduction of an enoyl-ACP intermediate. In other Enterobacteria such as E. coli and S. Typhimurium, FabI catalyzes this step; however, the
current annotation of the YP CO92 genome does not contain fabI. B. The enzyme ArgD catalyzes the sixth step in the nine-step lysine
biosynthesis pathway, but argD (YPO0170) is disrupted in YP CO92. YPO1962 has the greatest homology to YPO0170 within the Y. pestis CO92
genome, and we hypothesize here that YPO1962 can replace the function of YPO0170. Note: although each reaction in each pathway is
depicted as unidirectional, some are reversible.
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Page 5 of 13acid components in the BCS medium are present. Prior
experimental studies have reported the isolation of Y.
pestis clones that grow in media lacking the two amino
acids after several days incubation and attributed the
mechanism to meiotrophy [25]. We observed identical
behavior when we experimentally tested for glycine/
threonine auxotrophy in YP CO92: we could detect
growth one day after inoculating it into media supple-
mented with threonine, but glycine/threonine-deficient
media did not support growth until several days after
Figure 3 Analysis of possible defects within the Y. pestis CO92 rhamnose, melibiose, and glycerol uptake pathways. Epidemic Y. pestis
strains such as CO92 cannot utilize rhamnose, and YP CO92 cannot ferment glycerol. The dashed line indicates a reaction catalyzed by GlpD
(YPO3937) that is present in most other Enterobacteria but appears to be absent in YP CO92 due to a disruption in an underlying gene.
Abbreviations: rham, rhamnose; 1-P, 1-phosphate; 3-P: 3-phosphate; DHAP, dihydroxyacetone phosphate; melib, melibiose; glc-D, D-glucose;
galact, galactose; glyc, glycerol; OMP, outer membrane porin. The suffixes [e], [p], and [c] denote metabolites located in extracellular, periplasmic,
and cytoplasmic compartments, respectively.
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Page 6 of 13inoculation. Simulation results, however, suggest that
slow growth rather than meiotrophy might be sufficient
to explain the glycine/threonine phenotype. The model
does not exhibit any other amino acid auxotrophy.
To further evaluate the performance of the model
against experimental data, we tested whether YP CO92
could grow on eleven different carbon sources and com-
pared the data against simulation results. Initially, model
simulations correctly reproduced the experimental data
for ten of the eleven compounds (Table 2). Glycerol was
the only exception: the simulations originally permitted
growth on glycerol but no growth was seen when YP
CO92 was cultured in media containing glycerol as the
principal carbon source, a result that is consistent with
prior studies of YP CO92 [27]. It has been proposed that
a 93 bp deletion in glpD (YPO3937), which encodes aero-
bic glycerol 3-phosphate dehydrogenase, might render
the protein nonfunctional and account for this growth
phenotype [27]. There is a second glycerol 3-phosphate
dehydrogenase in the YP CO92 genome, gpsA
(YPO0068); however, the GpsA homolog in E. coli only
catalyzes the unidirectional conversion of dihydroxyace-
tone phosphate to glycerol 3-phosphate (Figure 3). The
protein cannot catalyze the reverse reaction, which is the
necessary direction for glycerol assimilation [28]. These
data were subsequently incorporated into the model to
make it more consistent with the observed glycerol-nega-
tive phenotype, but slow growth (0.07 hr
-1) still occurs in
silico despite these modifications because the model per-
mits glycerol to enter central metabolism indirectly
through the fatty acid biosynthesis and degradation path-
ways. Although not tested here, lactose represents
another discrepancy between model simulations and
experimental data (Additional File 1). None of the three
pathogenic Yersiniae can metabolize lactose, but model
simulations erroneously suggest that YP CO92 can.
For two of the eleven compounds (glucose and gluco-
nate), we also measured the uptake and secretion rates
for a set of metabolites during growth at 26°C, con-
strained the model according to the data (Additional File
1), and assessed the ability of the constrained model to
accurately compute growth rates on the two carbon
sources. Both growth media contained citrate in addition
to the two carbon sources; citrate is a common compo-
nent of the BCS medium routinely used to culture Yersi-
nia spp [24]. The simulated and experimental growth
rates agreed well on both sugars (Table 2) regardless of
the presence or absence of citrate in the simulation,
which suggests that YP CO92 utilizes negligible amounts
of citrate when either glucose or gluconate are present.
Gene Essentiality
We used the reconstruction to predict essential meta-
bolic genes in YP CO92 for growth on the same glucose
and gluconate defined media we used to culture the
bacterium (Figure 4). In total, 142 identical genes are
Table 2 Comparison between experimental data and model simulations for growth on eleven different carbon
sources.
Carbon
Source
Experimental Computational Comments
Gluconate Yes (0.27) Yes
Without citrate:
0.27
With citrate:
0.28
Glucose Yes (0.29) Yes
Without citrate:
0.28
With citrate:
0.28
Glycerol No Yes Model suggests glycerol can enter central metabolism indirectly through fatty acid biosynthesis and
degradation pathways, thereby permitting slow growth
Acetate Yes (0.14) Yes
Citrate Yes (0.086) Yes
Lactate Yes (0.12) Yes
Xylose Yes (0.20) Yes
Ribose Yes (0.17) Yes
Galactose Yes (0.16) Yes
Maltose Yes (0.27) Yes
Arabinose Yes (0.28) Yes
Values in parentheses in the Experimental column are the measured growth rates performed as part of this study. Values in parentheses in the Computational
column indicate model-predicted growth rates in BCS defined media with or without citrate and with glucose or gluconate as the principal carbon source.
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Page 7 of 13predicted to be essential on both media and at both
growth temperatures. An additional three genes,
YPO1139, YPO2063, and YPO3632, are predicted to be
essential at 25-28°C only. These three genes are involved
in the biosynthesis of two forms of lipid A that are pre-
sent only at 25-28°C [17]. A fourth gene, YPO3718 (pgi),
is predicted to be essential on gluconate only because its
deletion disrupts gluconeogenesis and consequently the
biosynthesis of glycogen, an indispensable component of
the YP CO92 biomass objective function. The full list of
genes predicted to be essential on the two media can be
found in Additional File 2.
The largest group of predicted essential genes falls
within amino acid transport and metabolism (28.3%).
Removal of genes in this subset imitates one of the
three amino acid auxotrophies that characterize this
strain. The next largest groups are nucleotide and coen-
zyme metabolism (17.3% each) followed by cell mem-
brane biogenesis (10.4%) and lipid metabolism (9.2%);
however, many genes in these groups were also deemed
to be essential according to the E. coli and S. Typhimur-
ium metabolic reconstructions on which many of the
gene-protein-reactions in iPC815 are based [8,9] (Addi-
tional File 2). This set of predicted essential genes there-
fore reflects probable overlap among the three models.
In turn, the overlap arises from what is likely common
biology that is shared within the family of Enterobacter-
iaceae. It might be possible to exploit this feature for
the development of broad-spectrum antibiotics targeted
against this group of human pathogens.
Discussion
Metabolic reconstructions constitute a framework to
organize genomic, proteomic, metabolomic, and other
data sets and to assess the effects of perturbations on
these elements at the network level. Accordingly, we
present a metabolic reconstruction for YP CO92, a
strain that is virulent to humans, and benchmark the
reconstruction qualitatively against experimental growth
data from eleven different carbon sources and quantita-
tively against growth rate and metabolite uptake and
secretion rate data from two of the sources.
The two gaps in lysine and fatty acid biosynthesis
highlighted in this work are significant because model
simulations cannot occur unless both gaps are filled.
The gap in lysine biosynthesis is noteworthy in that the
disrupted gene, YPO0170, encodes a bifunctional
enzyme, ArgD, that is involved in arginine biosynthesis
as well [29]: specifically, ArgD catalyzes the reversible
conversion of N-acetyl-L-glutamate 5-semialdehyde and
L-glutamate to N-acetyl-L-ornithine and 2-oxoglutarate,
after which N-acetyl-L-ornithine is converted to L-
ornithine. An absence of ArgD does not result in argi-
nine auxotrophy, however, because YP CO92 contains
an alternative, one-step route to L-ornithine from L-pro-
line that is catalyzed by YPO4090. This reaction is
included in the model. On the other hand, there is no
clear paralog or other mechanism within YP CO92 that
appears capable of replacing the missing fabI gene in
fatty acid biosynthesis. At the amino acid level, there is
only 28% identity between E. coli FabI and its best
match in YP CO92, YPO3351. We therefore sought to
identify possible candidate enzymes through an analysis
of expression data for YP CO92 [Schrimpe-Rutledge AC
and Adkins JN, unpublished data], reasoning that the
unidentified gene will be located near other genes
involved in fatty acid biosynthesis (specifically, the clus-
ter from YPO1597 (fabH) through YPO1601 (fabF)),
Figure 4 Breakdown by COG classification of 146 genes predicted to be essential in Y. pestis CO92. The 146 genes cover growth at both
25-28°C and 37°C and on both glucose and gluconate defined media (Additional File 2). The COG classifications that make up the Miscellaneous
category are: S, V, and Unassigned.
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ter, and be annotated as hypothetical. The best match
based on these criteria is the hypothetical gene
YPO1594. Consequently, we propose that YPO1594
might possess the ability to carry out the same catalytic
function as FabI. Other genes showing correlated
expression but located farther away from YPO1597-
YPO1601 are YPO3732 and YPO2055.
Pathway analysis and model simulations led to the
hypothesis that YP CO92 cannot utilize rhamnose and
melibiose due to a missing sink reaction and perturbed
gene regulation, respectively, but other possible mechan-
isms have been advanced. A disruption in gene regula-
tion might contribute to the rhamnose-negative
phenotype as well. Specifically, a recent study that com-
pared the sequences of rhamnose fermentation genes in
rhamnose-positive and rhamnose-negative strains sug-
gested that a point mutation in the transcriptional acti-
vator RhaS might be responsible for the rhamnose-
negative phenotype [30]. Experimental data from a prior
study indirectly support this claim [31]. Rhamnose-nega-
tive strains can revert and gain the ability to metabolize
the sugar at a low frequency, and an analysis of one
such strain found that RhaB and RhaA had become
active in the revertant [31]. Since RhaS regulates the
rhaBAD operon [32], these data imply that RhaS is the
key regulatory protein controlling rhamnose utilization
and that the mechanism involves rhaBAD. On the other
hand, melibiose metabolism might be absent in YP
CO92 because of one or more defects in inner mem-
brane transport. We identified two possible melibiose
symporters in YP CO92, YPO1582 and YPO0995
(melB). The former is the homolog of the putative meli-
biose symporter YP1470 from Y. pestis 91001, a strain
that can utilize melibiose [33], but the 5’ end of the cod-
ing sequence for YPO1582 has been disrupted by the IS
element IS285. YPO1582 is therefore presumed to be a
pseudogene. The latter is intact in YP CO92; however,
the IS element IS1661 is located approximately 250 bp
upstream from the 5’ end of melB, raising the possibility
that it has potentially disrupted the control of expres-
sion of melB. Proteomic data collected during mid-log
growth on BCS medium support this hypothesis: no
peptides for YPO0995 could be detected under these
growth conditions [Schrimpe-Rutledge AC and Adkins
JN, unpublished data].
Like rhamnose and melibiose, several hypotheses have
been advanced to explain why YP CO92 cannot metabo-
lize glycerol. Analysis of the YP CO92 genome sequence
revealed the presence of a 93 bp in-frame deletion in
glpD that might account for this phenotype: glpD
encodes aerobic glycerol 3-phosphate dehydrogenase, an
enzyme that is essential for glycerol utilization [27], and
this deletion likely disrupts protein function.
Intriguingly, this same deletion appeared in every gly-
cerol-negative strain in one culture collection whereas
all glycerol-positive strains from the same collection
contained an intact glpD [27]. There is a second anno-
tated glycerol 3-phosphate dehydrogenase within the YP
CO92 genome, gpsA,b u tt h egpsA homolog in E. coli
can only catalyze the transformation from dihydroxyace-
tone phosphate to glycerol 3-phosphate in an irreversi-
ble manner (Figure 3). A second defect occurs in the
glpFKX operon and might contribute to the glycerol-
negative phenotype as well: both the hypothetical pro-
tein glpX (YPO0089) and, more importantly, the glycerol
kinase glpK (YPO0090) have also been disrupted by
large deletions and are presumed to be pseudogenes. As
with glpD, there is a second annotated glycerol kinase in
the YP CO92 genome, YPO3312, but it is unknown
whether YPO3312 can duplicate the function of
YPO0090.
We saw slow growth for YP CO92 in both experimen-
tal measurements and model simulations in the absence
of glycine and threonine, and the model predicts that
this phenotype stems from insufficient supply of nitro-
gen. BCS medium does not contain an explicit source of
nitrogen such as NH4Cl; therefore, YP CO92 most likely
obtains elemental nitrogen through catabolism of one or
more amino acids. Glycine, threonine, and serine can all
interconvert. In turn, the breakdown of L-serine by L-
serine dehydratase (YPO1771) or L-threonine by L-
threonine dehydratase (YPO3896) leads to the direct
formation of NH3. Simulations that exclude glycine and
threonine from the in silico growth medium (serine is
not a component of BCS medium) force nitrogen acqui-
sition to occur through multi-step pathways that are less
efficient, leading to slower growth. Providing supple-
mental nitrogen through sources such as NH4Cl, in con-
trast, leads to a faster in silico growth rate that varies
with the uptake rate of the supplemental source.
It is well known that certain Y. pestis strains such as
C O 9 2d i s p l a ym e t h i o n i n ea u x o t r o p h y[ 2 5 , 2 6 ] ,a n dt h e
model highlights the importance of the methionine sal-
vage pathway to this phenotype. Several reactions in this
pathway are not currently associated with any genes in
YP CO92; however, if this pathway is absent, the bypro-
duct S-methyl-5’-thioadenosine (MTA) would be gener-
ated during reactions that consume S-adenosyl
methionine, but MTA itself would never be consumed
or degraded in any reaction. Such a situation is identical
to the formation of L-lactaldehyde during rhamnose uti-
lization and results in the same thermodynamically
impossible outcome. Furthermore, this pathway is fully
annotated in other Y. pestis s t r a i n ss u c ha sP e s t o i d e sF
and Angola, suggesting that it is present in YP CO92 as
well but that the associated genes remain to be identi-
fied. For these reasons, the model includes a set of non-
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methionine via the methionine salvage pathway, and
predicts that these reactions are essential in YP CO92.
Conclusions
The analyses presented here concerning lysine, fatty
acid, amino acid, rhamnose, melibiose, and glycerol
metabolism help to illustrate how flux-balance analysis
(FBA) of well-curated metabolic models can provide a
context for interpreting experimental data. The crucial
information provided by FBA is pathway utilization:
whereas visual inspection of static pathway diagrams
alone can indicate whether a certain pathway is present
or absent in an organism, visual inspection cannot indi-
cate whether a certain pathway carries flux and is there-
fore utilized. In contrast, FBA can provide this insight.
For example, YP CO92 appears to have the ability to
metabolize rhamnose because a complete set of genes
and reactions connects imported rhamnose to central
metabolism, but FBA analysis suggests that the absence
of L-lactaldehyde degradation prevents this pathway
from being utilized. Similarly, the gaps in lysine and
fatty acid biosynthesis are readily apparent when gen-
o m ea n n o t a t i o nd a t ai so v e r l a i do ns t a t i cd i a g r a m sf o r
the two pathways, but the model highlights the impor-
tance of these gaps - that they are essential reactions -
since growth simulations cannot take place unless the
gaps are filled. Looking forward, we anticipate that this
reconstruction will serve as a platform with which to
reconstruct the metabolism of other strains within the
Yersinia genus and to integrate and interrogate -omics
data sets generated for these organisms. Integrated mod-
els for other pathogens have already provided insight
into important phenomena such as drug-target networks
[34,35] and host-pathogen interactions [36]. Similar
efforts for YP CO92 would further underscore the value
that metabolic models bring to the interpretation of
experimental data and likely generate additional impor-
tant and testable hypotheses for this dangerous human
pathogen.
Methods
Reconstruction approach
The YP CO92 model iPC815 was reconstructed via a
four-step process [37,38]. The first step was to build a
draft reconstruction. The complete list of metabolic
genes in the YP CO92 genome [21] was assembled
from the NCBI Reference Sequence database [39] down-
loaded on 1 May 2009 (RefSeq accession NC_003143).
Next, we performed homology mapping between YP
CO92 and E. coli K12 MG1655 and between YP CO92
and Salmonella enterica serovar Typhimurium LT2.
The three bacteria are all closely-related enterobacteria
and published reconstructions for both E. coli [8] and S.
Typhimurium LT2 [9] already exist. Homologous meta-
bolic genes in E. coli and S. Typhimurium were carried
over to form the initial YP CO92 reconstruction.
Homology was determined through one of the follow-
ing: (1) a Smith-Waterman protein search [40] with a
query of all curated metabolic genes from both models
and a list of all predicted proteins in YP CO92 using
SSearch [41]; (2) a DNA search for all curated meta-
bolic ORFs in the Y. pestis CO92 genome using FASTA
[41]; and (3) a translated protein search for all curated
m e t a b o l i cp r o t e i n si nt h eY PC O 9 2g e n o m eb yu s i n g
tfasty [41]. A gene was considered shared if at least one
of these three methods produced an alignment with a
minimum of 75% sequence conservation over 75% of
the query gene length. These cutoffs were chosen by
comparing the published E. coli [8] and S. Typhimurium
[9] metabolic reconstructions. With E. coli as the refer-
ence and S. Typhimurium as the query, these cutoffs
led to approximately 75% overlap between the two
models and a 2.5% false positive rate, defined here as
the number of E. coli genes predicted to have homologs
in S. Typhimurium but that did not carry over after
manual curation.
With the final list of shared metabolic genes, we
returned to the previously published metabolic recon-
structions, this time focusing on the potential for shared
reactions instead of shared genes. A reaction was con-
sidered shared if it had a complete gene-protein-reaction
association (GPR) in the YP CO92 model. A complete
GPR is one in which all genes required to catalyze a
particular reaction are present. For example, a GPR in
the E. coli or S. Typhimurium models catalyzed by gene
1 AND gene 2 was ported to the YP CO92 model only
if YP CO92 was deemed to have homologs for both
gene 1 and gene 2. If neither or only one of the two
genes was present, the reaction was not considered
shared and was not ported.
Reactions known to be spontaneous in both the E. coli
and Salmonella models were also added to the YP
CO92 model, completing the draft YP CO92 metabolic
reconstruction. Reactions without gene-protein associa-
tions ("orphan” reactions) were not ported.
The second step was model refinement. We searched
approximately 2700 publications in PubMed using the
keywords “Yersinia” and “metab*” to collect experimen-
tal data for as many genes in the draft reconstruction as
possible. Our search focused on the YP CO92 strain in
particular, but we also noted any relevant data from any
species within the Yersinia genus. We used the PATRIC
[13], KEGG [10], and other databases in our search as
well. Genes, proteins, and reactions in the draft recon-
struction were updated according to the experimental
data uncovered during these searches. All reactions were
then mass- and charge-balanced.
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tion into a mathematical format suitable for computa-
tion, the stoichiometric matrix (S-matrix), and to
develop explicit mathematical equations for the biomass
objective functions (BOF). The model contains two
BOFs that simulate biomass formation at 25-28°C and
37°C. Both are derived from similar BOFs constructed
for the published Y. pestis 91001 metabolic model [7]
and modified to incorporate additional lipid composition
and lipopolysaccharide (LPS) data as follows. First, the
model contains explicit biosynthesis pathways for the
14:0 (including 3’-OH-14:0), 16:1, 16:0, and 18:1 fatty
acid chain lengths since these four dominate the fatty
acid composition in Y. pestis at 27-28°C [15,42]. We
could not find fatty acid composition data for Y. pestis
at 37°C, but we assume that this distribution also holds
at 37°C based on data from Y. enterocolitica at 37°C
[18]. Accordingly, we subdivided cardiolipin (clpn),
phosphatidylethanolamine (pe), and phosphatidylglycerol
(pg) such that each of the three contains all four acyl
groups in both BOFs. Second, the LPS differs between
the two temperatures: in Y. pestis KIM218, another bio-
var Orientalis strain, galactose is present as one of the
monomer units in the core oligosaccharide at 25°C but
not 37°C [17]. Moreover, the core oligosaccharide at
both 25°C and 37°C contains one 3-deoxy-D-manno-
oct-2-ulosonic acid (Kdo) and one D-glycero-D-talo-oct-
2-ulosonic acid (Ko) rather than two Kdo residues,
which is the more common structure in Gram-negative
bacteria [16,17]. The composition of the acyl chains
attached to the core oligosaccharide also varies with
temperature [17]. Y. pestis CO92 LPS does not contain
O-antigen at either temperature [43].
The fourth step was model evaluation and debugging.
Critical gaps preventing in silico production of biomass
precursor metabolites were filled by identifying and add-
ing to the model enzymes with the potential to catalyze
the missing reaction(s). These candidates were gleaned
from primary literature, genome annotation, and data-
base sources such as KEGG and PATRIC. A similar
pathway analysis procedure was used to ensure that the
model reproduced known YP CO92 amino acid auxo-
trophies [26].
The model (S-matrix) was implemented in Matlab and
flux balance analysis (FBA) performed using the
COBRA Toolbox and glpk solver [44]. The S-matrix is
an m by n matrix containing m metabolites and n reac-
tions. The relationship between reactions and the con-
centration time derivatives is:
dx
dt
= S · v
where x and v denote the vector of metabolite concen-
trations and reaction fluxes, respectively. Steady-state
FBA is performed by solving the following linear optimi-
zation problem:
maximize(cT · v)
subject S · v =0a n dl b< v < ub
The reaction fluxes are constrained by thermodynamic
and reaction kinetics and lie between lower (lb) and
upper (ub) bounds. The optimization vector (c)i sa
zero-vector except for one element that has a value of
one and corresponds to the reaction to be optimized,
which in the model is one of the two BOFs. Model con-
straints during simulations were set by either experi-
mental data collected as part of this study (Additional
File 1) or, if certain uptake rates or other experimental
data were not available, by setting the lower bound to
the initial concentration of that particular compound in
the experimental BCS growth medium [24]. A minimal
medium consisting of a carbon, nitrogen, phosphorus
and sulfur source plus unconstrained amounts of Ca
2+,
Cl
-,F e
2+,H 2O, H
+,K
+,M g
2+,M n
2+,O 2,P O 4
3-,S O 4
2-,
pantothenate, and thiamin was used during simulations
to investigate the ability of different sources of the four
elements to support in silico growth (Additional File 1).
These chemicals are present in BCS medium [24]. To
examine gene essentiality, genes were removed from the
model and the resulting flux through the BOF assessed.
Zero flux through the BOF was taken to be an indicator
of an in silico essential gene.
The reconstruction has been made available in sbml
format as Additional File 3.
Cultivation
Y. pestis CO92 was grown in a chemically defined BCS
medium [24] in which neutral pH (7.2) was maintained
by the addition of 50 mM of morpholinopropanesulfonic
acid (MOPS) as described previously [45]. The medium
contained 4 mM CaCl2 and one of the carbon sources
at a concentration of 0.2%. Bacterial cultures were
grown at 26°C in Erlenmeyer flasks aerated at 200 rpm.
The first culture was grown during daytime, and then
overnight culture was initiated at an optical density at
600 nm (OD600)o f0 . 1 .B o t ht h ef i r s ta n ds e c o n dc u l -
tures contained 0.2% potassium gluconate as a carbon
source [45], and the overnight culture typically reached
an OD600 of ~3.0. The third culture was obtained from
bacteria grown overnight, washed twice with 33 mM
potassium phosphate buffer pH 7.0, and inoculated into
fresh media containing one of the eleven tested carbon
sources to an initial OD600 of 0.05. Aliquots from
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points to measure OD600 and to prepare samples for
metabolite identification and uptake/secretion measure-
ments. These samples were obtained by centrifugation
of 1.5 ml of bacterial culture at 10,000 rpm for 2 min-
utes at 4°C followed by filtration of the supernatants
through a 0.2 μm low binding polyethersulfone mem-
brane filter (Corning Life Sciences, Lowell, MA). Sam-
ples were then immediately frozen and stored at -80°C.
1H NMR Spectroscopy and Metabolite Quantification
540 μL of spent media extracts were added to 60 μLo f
5 mM 2,2-dimethyl-2-silapentane-5-sulfonate (DSS) in
99.9% deuterium oxide (D2O) in 5-mm NMR tubes.
DSS is used as an internal standard and to provide a
1H
chemical shift reference at δ 0.00 ppm.
1H NMR spectra
were acquired on a Varian INOVA-600 MHz NMR
spectrometer (Varian Inc., Palo Alto, CA) at 298 K,
using a triple resonance 5-mm HCN salt-tolerant cold
probe. A one-dimensional NOE pulse sequence adapted
from the two-dimensional Varian tnnoesy was used. For
each sample, 96 transients were collected into 64 K data
points using a spectral width of 7225.4 Hz with a relaxa-
tion delay of 1.0 s, an acquisition time of 4.00 s, and a
mixing time of 100 ms. Spectra were processed using
Chenomx 6.1. A 0.5-Hz line-broadening function was
applied to all spectra prior to Fourier Transformation
(FT) and baseline correction. The profiler module of
Chenomx was used to identify and quantify metabolites.
Additional material
Additional file 1: Model details. A. Table of contents. B. Gene list. C.
Metabolites. D. Reactions and their associated genes (if any). E. Biomass
objective functions. F. Comparison between iPC815 and the YP 91001
model of Navid, et al. G. Growth simulations on different carbon sources.
H. Growth simulations on different nitrogen sources. I. Growth
simulations on different phosphorus sources. J. Growth simulations on
different sulfur sources. K. Individual components in BCS growth
medium. L. Substrate uptake and secretion rates used to constrain model
simulations.
Additional file 2: Gene essentiality. A. List of genes predicted to be
essential in YP CO92. Homologous genes in E. coli and Salmonella
Typhimurium LT2 that were predicted to be essential by the E. coli
iAF1260 model [8] and the Salmonella Typhimurium LT2 consensus
model [9] have been listed as well. B. List of genes predicted to be
essential in E. coli only (from [8]). C. List of genes predicted to be
essential in S. Typhimurium only [9].
Additional File 3: The iPC815 model in SBML format.
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